Ito M - Search Results

1

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.

Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, Shirakawa Y, Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y. Tabuchi Y, et al. Among authors: ito m. Int J Oncol. 2009 Feb;34(2):313-9. Int J Oncol. 2009. PMID: 19148464

2

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.

Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J. Sugiu K, et al. Among authors: ito m. Acta Med Okayama. 2015;69(5):291-9. doi: 10.18926/AMO/53675. Acta Med Okayama. 2015. PMID: 26490026 Free article. Clinical Trial.

3

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).

Saji S, Ohsumi S, Ito M, Hayashi N, Kobayashi K, Masuda N, Niikura N, Yamashita T, Kiyama K, Hasegawa A, Nakagawa S, Hattori M. Saji S, et al. Among authors: ito m. Jpn J Clin Oncol. 2022 Oct 6;52(10):1124-1133. doi: 10.1093/jjco/hyac098. Jpn J Clin Oncol. 2022. PMID: 35750038 Free PMC article. Clinical Trial.

4

Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial.

Kin T, Ohtani S, Maeda R, Ueno A, Fujihara M, Takamatsu Y, Kajiwara Y, Ito M, Kawasaki K, Abe K, Sakata Y, Hiraki K. Kin T, et al. Among authors: ito m. World J Oncol. 2020 Oct;11(5):197-203. doi: 10.14740/wjon1333. Epub 2020 Oct 15. World J Oncol. 2020. PMID: 33117463 Free PMC article.

5

Accumulation of CD56⁺ CD16^- Natural Killer Cells in Response to Preoperative Chemotherapy for Breast Cancer.

Kim R, Kawai A, Wakisaka M, Shimoyama M, Yasuda N, Ito M, Kin T, Arihiro K. Kim R, et al. Among authors: ito m. World J Oncol. 2024 Aug;15(4):682-694. doi: 10.14740/wjon1885. Epub 2024 Jul 5. World J Oncol. 2024. PMID: 38993254 Free PMC article.

6

A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.

Kim R, Kawai A, Wakisaka M, Funaoka Y, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Arihiro K. Kim R, et al. Among authors: ito m. Cancer Immunol Immunother. 2019 Apr;68(4):577-585. doi: 10.1007/s00262-019-02305-z. Epub 2019 Jan 23. Cancer Immunol Immunother. 2019. PMID: 30673828 Free PMC article.

7

Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer.

Kim R, Kawai A, Wakisaka M, Sawada S, Shimoyama M, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Kawasaki K, Kin T, Arihiro K. Kim R, et al. Among authors: ito m. Transl Oncol. 2021 Jan;14(1):100927. doi: 10.1016/j.tranon.2020.100927. Epub 2020 Nov 3. Transl Oncol. 2021. PMID: 33157515 Free PMC article.

8

Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients.

Fujihara M, Yamasaki R, Ito M, Shien T, Maeda R, Kin T, Ueno A, Kajiwara Y, Kawasaki K, Ichimura K, Mihara H, Kimura N, Ohtani S. Fujihara M, et al. Among authors: ito m. BMC Womens Health. 2021 Apr 10;21(1):147. doi: 10.1186/s12905-021-01287-4. BMC Womens Health. 2021. PMID: 33838670 Free PMC article.

9

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.

10

Radiofrequency ablation of early breast cancer followed by delayed surgical resection--a promising alternative to breast-conserving surgery.

Ohtani S, Kochi M, Ito M, Higaki K, Takada S, Matsuura H, Kagawa N, Hata S, Wada N, Inai K, Imoto S, Moriya T. Ohtani S, et al. Among authors: ito m. Breast. 2011 Oct;20(5):431-6. doi: 10.1016/j.breast.2011.04.007. Epub 2011 Jun 8. Breast. 2011. PMID: 21641802 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,037 results

Search Page

Filters